Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for Early Phase Prevention Trials

Publication Year
Results: 22 (Showing 1 to 20)
Title PubMed Authors Journal Year Studies
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects. 38171245 Lee O , Bazzi LA , Xu Y , Pearson E , Wang M , Hosseini O , Akasha AM , Choi JN , Karlan S , Pilewskie M , Kocherginsky M , Benante K , Helland T , Mellgren G , Dimond E , Perloff M , Heckman-Stoddard BM , Khan SA Biomed Pharmacother 2024 EPPT
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy Tanabe, K. K., Zahrieh, D., Strand, C. A., Hoshida, Y., Flotte, T. J., Della’Zanna, G., Umar, A., Chavin, K. D., Cleary, S., Kubota, N., Llovet, J. M., Patel, T., Siegel, C., & Limburg, P. J. Gastro Hep Advances 2024 EPPT
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer Parijatham S. Thomas, Anisha B. Patel, J. Jack Lee, Diane D. Liu, Mike Hernandez, Miguel Muzzio, Alejandro Contreras, Valerie Sepeda, Carrie Mays, Diane Weber, Lana A. Vornik, Seema A. Khan, Eileen Dimond, Brandy M. Heckman-Stoddard, Marjorie Perlof… Cancer Prev Res 2023 EPPT
Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment Miller YE, Ghosh M, Merrick DT, Kubala B, Szabo E, Bengtson L, Kocherginsky M, Helenowski IB, Benante K, Schering T, Kim J, Kim H, Ha D, Bergan RC, Khan SA and Keith RL Front. Oncol. 2023 EPPT
Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. 37870954 Khan SA , Mi X , Xu Y , Blanco LZ , Akasha AM , Pilewskie M , Degnim AC , AlHilli Z , Amin AL , Hwang ES , Guenther JM , Kocherginsky M , Benante K , Zhang S , Helland T , Hustad SS , Gursel DB , Mellgren G , Dimond E , Perloff M , Heckman-Stoddard … JAMA Surg 2023 EPPT
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial. 36951827 Serrano D , Gandini S , Thomas P , Crew KD , Kumar NB , Vornik LA , Lee JJ , Veronesi P , Viale G , Guerrieri-Gonzaga A , Lazzeroni M , Johansson H , D'Amico M , Guasone F , Spinaci S , Bertelsen BE , Mellgren G , Bedrosian I , Weber D , Castile T ,… JAMA Oncol 2023 EPPT
Clinical Study of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers. 35740559 Garland LL, Guillen-Rodriguez J, Hsu CH, Davis LE, Szabo E, Husted CR, Liu H, LeClerc A, Alekseyev YO, Liu G, Bauman JE, Spira AE, Beane J, Wojtowicz M, Chow HS Cancers (Basel) 2022 EPPT
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis. 35636921 Samadder NJ, Foster N, McMurray RP, Burke CA, Stoffel E, Kanth P, Das R, Cruz-Correa M, Vilar E, Mankaney G, Buttar N, Thirumurthi S, Turgeon DK, Sossenheimer M, Westover M, Richmond E, Umar A, Della'Zanna G, Rodriguez LM, Szabo E, Zahrieh D, Limbur… Gut 2022 EPPT
Randomized Crossover Trial Evaluating Detoxification of Tobacco Carcinogens by Broccoli Seed and Sprout Extract in Current Smokers. 35565256 Bauman JE, Hsu CH, Centuori S, Guillen-Rodriguez J, Garland LL, Ho E, Padi M, Bageerathan V, Bengtson L, Wojtowicz M, Szabo E, Chow HS Cancers (Basel) 2022 EPPT
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance. 36517408 Parsons JK , Pinto PA , Pavlovich CP , Uchio E , Nguyen MN , Kim HL , Gulley JL , Sater HA , Jamieson C , Hsu CH , Wojtowicz M , House M , Schlom J , Donahue RN , Dahut WL , Madan RA , Bailey S , Centuori S , Bauman JE , Parnes HL , Chow HS Eur Urol Focus 2022 EPPT
A Randomized, Double-Blinded, Placebo-Controlled Trial of Simvastatin to Prevent Recurrent Pancreatitis. 35195610 Goodman MT , Lo SK , Yadav D , Wu BU , Jamil LH , Kwok KK , Papachristou GI , Afghani E , Choi-Kuaea Y , Waldron RT , Lombardi C , Jeon CY , Helenowski IB , Richmond E , Benante K , Habtezion A , Schering T , Khan SA , Rodriguez LM , Pandol SJ Pancreas 2022 EPPT
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance. 33095939 Jarrard D, Filon M, Huang W, Havighurst T, DeShong K, Kim K, Konety BR, Saltzstein D, Mukhtar H, Wollmer B, Suen C, House MG, Parnes HL, Bailey HH Prostate 2021 EPPT
Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double-Blind, Placebo-Controlled Phase II Trial. 32996592 Lee O, Pilewskie M, Karlan S, Tull MB, Benante K, Xu Y, Blanco L, Helenowski I, Kocherginsky M, Yadav S, Hosseini O, Hansen N, Bethke K, Muzzio M, Troester MA, Dimond E, Perloff M, Heckman-Stoddard B, Khan SA Clin Pharmacol Ther 2021 EPPT
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. 34255745 Gutkind JS, Molinolo AA, Wu X, Wang Z, Nachmanson D, Harismendy O, Alexandrov LB, Wuertz BR, Ondrey FG, Laronde D, Rock LD, Rosin M, Coffey C, Butler VD, Bengtson L, Hsu CH, Bauman JE, Hewitt SM, Cohen EE, Chow HS, Lippman SM, Szabo E JCI Insight 2021 EPPT
Vadis trial: Phase II trial of nelipepimut-s peptide vaccine in women with DCIS of the breast Anne E O'Shea; Guy T Clifton; Na Qiao; Brandy Heckman-Stoddard; Malgorzata Wojtowicz; Eileen Dimond; Isabelle Bedrosian; Diane Weber; Alex Husband; Ricardo Pastorello; Lana Vornik; George Peoples; Elizabeth A Mittendorf Cancer Res 2021 EPPT
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. 32641470 Reyes-Uribe L, Wu W, Gelincik O, Bommi PV, Francisco-Cruz A, Solis LM, Lynch PM, Lim R, Stoffel EM, Kanth P, Samadder NJ, Mork ME, Taggart MW, Milne GL, Marnett LJ, Vornik L, Liu DD, Revuelta M, Chang K, You YN, Kopelovich L, Wistuba II, Lee JJ, Sei… Gut 2020 EPPT
Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II Trial. 33409459 Bonanni B, Serrano D, Maisonneuve P, Veronesi G, Johansson H, Aristarco V, Varricchio C, Cazzaniga M, Lazzeroni M, Rampinelli C, Bellomi M, Vecchi M, Spaggiari L, Vornik L, Brown PH, Beavers T, Guerrieri-Gonzaga A, Szabo E JNCI Cancer Spectr 2020 EPPT
Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial. 31451521 Garland LL, Guillen-Rodriguez J, Hsu CH, Yozwiak M, Zhang HH, Alberts DS, Davis LE, Szabo E, Merenstein C, Lel J, Zhang X, Liu H, Liu G, Spira AE, Beane JE, Wojtowicz M, Chow HS Cancer Prev Res (Phila) 2019 EPPT
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers. 31484659 Kolesar JM, Andrews S, Green H, Havighurst TC, Wollmer BW, DeShong K, Laux DE, Krontiras H, Muccio DD, Kim K, Grubbs CJ, House MG, Parnes HL, Heckman-Stoddard BM, Bailey HH Cancer Prev Res (Phila) 2019 EPPT
A Phase I Trial of Berberine in Chinese with Ulcerative Colitis. 31619442 Xu L, Zhang Y, Xue X, Liu J, Li ZS, Yang GY, Song Y, Pan Y, Ma Y, Hu S, Wen A, Jia Y, Rodriguez LM, Tull MB, Benante K, Khan SA, Cao Y, Jovanovic B, Richmond E, Umar A, Bergan R, Wu K Cancer Prev Res (Phila) 2019 EPPT